A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer
Status:
Not yet recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label, pharmacokinetic comparison study of SYHX2011 and
Abraxane® in patients with advanced breast cancers after single IV infusion.